Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
about
Atherosclerosis and infection: is the jury still not in?Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control studyChlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysisThe SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDLLong-term trends in cardiovascular disease mortality and association with respiratory disease.Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective.The effect of proatherogenic pathogens on adipose tissue transcriptome and fatty acid distribution in apolipoprotein E-deficient mice.Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatisThe seroprevalence of Mycoplasma pneumoniae IgM and IgG antibodies in patients with ischemic strokeInnate and adaptive immunity in atherosclerosis.Infectious burden and risk of stroke: the northern Manhattan study.Infectious burden and carotid plaque thickness: the northern Manhattan study.Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trialChlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.Does non-central nervous system tuberculosis increase the risk of ischemic stroke? A population-based propensity score-matched follow-up study.Infectious burden: a new risk factor and treatment target for atherosclerosis.Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemiaEffects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J micePorphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells.Modulation of atherosclerosis in mice by Toll-like receptor 2Chlamydia pneumoniae encodes a functional aromatic amino acid hydroxylase.The oxidative stress product carboxyethylpyrrole potentiates TLR2/TLR1 inflammatory signaling in macrophagesInflammatory mechanisms of stroke.Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis.Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression.Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control studyAtherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureProspects for the medical management of abdominal aortic aneurysms.Chlamydia uncloaked.Chlamydia psittaci genetic variants differ in virulence by modulation of host immunityPersistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarctionGiant cell arteritis and cardiovascular disease in older adults.Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?Hyperhomocysteinemia and immune activation.Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analoguesChlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein.
P2860
Q22241306-B635637C-0ABE-4743-8F7F-2A4748E73758Q24805877-71DD9824-49C3-48E7-AC41-74E78EE96952Q26859186-03E720D1-D688-420A-8220-B63A1351CF37Q26991782-8E7A769D-0E34-41B6-8152-2A73F6ABEC29Q30377539-05754AF1-1BC4-4996-A923-A1681D531C15Q33306319-1D1B6AD1-5E4A-4903-871E-83A030FF3129Q33558862-758FF185-E7BF-4325-9B52-1A73BBA5553AQ33640286-4D65B15A-6472-42A5-95B9-42AE2FD0F5ACQ33645328-6FB3C608-CFD1-49DC-87A7-49487D3CD644Q33659705-618B4B20-293E-4296-9D2E-F72AB2E689A5Q33697873-5868CAA1-2804-43D3-B95A-673B21531882Q33697959-F4B29EDF-A85C-4AE0-8F72-86EA182CB030Q33752851-D9B6BA3C-C202-4021-9675-4D00DE8ACC57Q33927267-D00E7B02-7340-47BE-B0E3-15D628EA4F95Q33927923-D920DF72-11BD-4ACA-AD70-E45CEA4DF860Q33936406-F5266DE0-A8FB-458F-9940-865F58C1A2F7Q33997331-A27D9AF2-9FA6-4B41-AE37-CB7E3E3A7BF2Q34033240-E0E6DA67-61C3-43FE-BBD5-386996B41416Q34034262-E6C08823-E799-4910-8B36-7E37131B01B3Q34063165-8E875F0F-9578-4DDF-A02D-BFC9D91E68F2Q34066394-FAA93342-745D-4650-86E1-7DB6D35425A2Q34128646-2D7F4BCB-F462-497D-9D7D-A284C033CFA1Q34235537-1057E636-2BA5-471B-91F7-343E78422113Q34781808-E2D494B7-2BE1-4292-987F-B9DF468ABFC3Q35035253-59FAF9CF-A360-4EEB-8ABF-76CB82FD2AF3Q35088021-332EE720-D756-4D63-A84B-ECDCB8D690EEQ35121619-2C34954F-8A65-49FC-A985-1D37F7CF996DQ35127516-E0AD97DA-7E0D-489B-A01C-3C940972E468Q35150958-9CB78186-8BAF-4900-A6AB-FD21FC33CFD1Q35167017-477EE796-F295-47C8-BCB0-0DEA41727799Q35465997-FBFD3067-F215-47B2-AF0B-49C0166D463AQ35570353-C47F4A76-F463-4E15-929D-A46CE4609C58Q35583758-E1724EC9-EA37-43B4-A838-D13CB4F8E2A6Q35590958-0E6B17D2-3DF4-41BB-9F26-712762FB6821Q35600432-70D3AC62-50A8-41C0-B659-0F225C21EB08Q35701591-0CC3A764-7E18-465C-9B07-7E5BCABA3851Q35709736-99641458-BE4E-458D-A285-DD763253EBD2Q35737359-40B1290F-7770-4D28-9F09-DFEA2EF1E5C4Q35758705-500FE424-58C8-4E0B-8251-AD106908BF34Q35879416-95F51489-5570-48EE-8CF1-63078E078020
P2860
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@ast
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@en
type
label
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@ast
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@en
prefLabel
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@ast
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@en
P356
P1476
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
@en
P2093
Gerald I Byrne
Murat V Kalayoglu
P304
P356
10.1001/JAMA.288.21.2724
P407
P50
P577
2002-12-01T00:00:00Z